newsroom
$HIMS · hims figured something out
now playing · $HIMS
$HIMS···bullish· high· posantonio linares
Hims enters AIP moment: building two-sided healthcare OS with $2,000 price target by 2030
Hims has shifted from selling pills to a token-based intelligence platform where proprietary biomarker data from labs and GLP-1 treatments trains an AI doctor, creating a winner-t…
$IBRX···bullish· medium· posantonio linares
Host discloses ImmunityBio shareholding tied to Anktiva IL-15 super agonist thesis
Holds shares based on Anktiva (IL-15 super agonist) as part of the broader 'writing code in the biological system' thesis where peptides and immunotherapies become programmable tr…